Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study-Reference-Cited by-同舟云学术

Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study

Published:2022-09-29 Issue:3 Volume:28 Page:262-272
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Dawes Timothy J. W.¹^ORCID,McCabe Colm¹²^ORCID,Dimopoulos Konstantinos¹²³^ORCID,Stewart Iain¹^ORCID,Bax Simon²,Harries Carl²,Samaranayake Chinthaka B.¹^ORCID,Kempny Aleksander¹²³^ORCID,Molyneaux Philip L.¹⁴^ORCID,Seitler Samuel²^ORCID,Semple Thomas¹⁵^ORCID,Li Wei¹³⁶^ORCID,George Peter M.¹⁴^ORCID,Kouranos Vasileios¹⁴^ORCID,Chua Felix¹⁴^ORCID,Renzoni Elisabetta A.¹⁴^ORCID,Kokosi Maria¹⁴^ORCID,Jenkins Gisli¹⁴^ORCID,Wells Athol U.¹⁴^ORCID,Wort Stephen J.¹²^ORCID,Price Laura C.¹²^ORCID

Affiliation:

1. National Heart and Lung Institute, Imperial College London London UK

2. National Pulmonary Hypertension Service Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London UK

3. Adult Congenital Heart Disease Service Royal Brompton Hospital London UK

4. Department of Interstitial Lung Disease Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London UK

5. Department of Radiology Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London UK

6. Department of Echocardiography Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London UK

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.14378

Reference46 articles.

1. Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis

2. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension

3. A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis

4. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

5. Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting;Respiratory Medicine and Research;2024-11

2. Predicting Peri-Operative Cardiorespiratory Adverse Events in Children with Idiopathic Pulmonary Arterial Hypertension Undergoing Cardiac Catheterization Using Echocardiography: A Cohort Study;Pediatric Cardiology;2024-03-21

3. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023);Eurasian heart journal;2024-03-11

4. Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?;Thorax;2024-02-02

5. Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future;Frontiers in Medicine;2024-01-17